Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950123-10-059797
Filing Date
2010-06-22
Accepted
2010-06-22 09:00:35
Documents
8
Effectiveness Date
2010-06-22

Document Format Files

Seq Description Document Type Size
1 DEFA14A a56553dadefa14a.htm DEFA14A 25032
2 GRAPHIC a56553daa5655301.gif GRAPHIC 3832
3 GRAPHIC a56553daa5655302.gif GRAPHIC 695
4 GRAPHIC a56553daa5655303.gif GRAPHIC 435
5 GRAPHIC a56553daa5655304.gif GRAPHIC 381
6 GRAPHIC a56553daa5655305.gif GRAPHIC 1771
7 GRAPHIC a56553daa5591610.gif GRAPHIC 61182
8 GRAPHIC a56553daa5591611.gif GRAPHIC 69702
  Complete submission text file 0000950123-10-059797.txt   217819
Mailing Address 157 TECHNOLOGY DR IRVINE CA 92618
Business Address 157 TECHNOLOGY DR IRVINE CA 92618 9497886700
SPECTRUM PHARMACEUTICALS INC (Filer) CIK: 0000831547 (see all company filings)

EIN.: 930979187 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-28782 | Film No.: 10909222
SIC: 2834 Pharmaceutical Preparations